Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00084-5/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-8N2rtCr6A5ZeEO6OMMn63YEwIy1zyxnD0MWjaqwyz1Yj1BxDeh7zVJ6GLUM2CwbsyfiesMqyLPH9PscEPqN2D-us0IPw&_hsmi=310298690&utm_content=310269965&utm_source=hs_email